These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16026775)

  • 1. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.
    Yagihashi A; Ohmura T; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Hirata K; Watanabe N
    Clin Chim Acta; 2005 Dec; 362(1-2):125-30. PubMed ID: 16026775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.
    Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Shijubo Y; Abe S; Hirohashi Y; Torigoe T; Sato N; Watanabe N
    Lung Cancer; 2005 May; 48(2):217-21. PubMed ID: 15829321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-survivin and anti-livin antibodies].
    Yagihashi A
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():708-10. PubMed ID: 20942170
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.
    Tanabe H; Yagihashi A; Tsuji N; Shijubo Y; Abe S; Watanabe N
    Lung Cancer; 2004 Dec; 46(3):299-304. PubMed ID: 15541814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to survivin and their clinical significance in patients with head and neck cancer.
    Eto M; Kodama S; Uemura N; Suzuki M
    Head Neck; 2007 Dec; 29(12):1128-35. PubMed ID: 17636541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of livin in renal cell carcinoma and detection of anti-livin autoantibody in patients.
    Kitamura H; Honma I; Torigoe T; Hariu H; Asanuma H; Hirohashi Y; Sato E; Sato N; Tsukamoto T
    Urology; 2007 Jul; 70(1):38-42. PubMed ID: 17656204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma.
    Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Watanabe N
    Autoimmunity; 2005 Sep; 38(6):445-8. PubMed ID: 16278150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic tests: Anti-Survivin and anti-Livin antibodies].
    Yagihashi A
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():637-9. PubMed ID: 16111355
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy.
    Kitamura H; Torigoe T; Honma I; Asanuma H; Nakazawa E; Shimozawa K; Hirohashi Y; Sato E; Sato N; Tsukamoto T
    Urology; 2006 May; 67(5):955-9. PubMed ID: 16635519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
    Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
    Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to survivin in the sera of patients with infiltrating ductal carcinoma of the breast.
    Al-Joudi FS; Iskandar ZA
    Med J Malaysia; 2006 Aug; 61(3):302-6. PubMed ID: 17240580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients.
    Rohayem J; Diestelkoetter P; Weigle B; Oehmichen A; Schmitz M; Mehlhorn J; Conrad K; Rieber EP
    Cancer Res; 2000 Apr; 60(7):1815-7. PubMed ID: 10766164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
    Mainou-Fowler T; Overman LM; Dignum H; Wood K; Crosier S; Angus B; Proctor SJ; Anderson JJ
    Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions.
    Kleinberg L; Flørenes VA; Nesland JM; Davidson B
    Am J Clin Pathol; 2007 Sep; 128(3):389-97. PubMed ID: 17709312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection.
    Megliorino R; Shi FD; Peng XX; Wang X; Chan EK; Tan EM; Zhang JY
    Cancer Detect Prev; 2005; 29(3):241-8. PubMed ID: 15896923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to the inhibitor of apoptosis protein survivin in patients with brain tumors.
    Söling A; Plugge EM; Schmitz M; Weigle B; Jacob R; Illert J; Holzhausen HJ; Rainov NG
    Int J Oncol; 2007 Jan; 30(1):123-8. PubMed ID: 17143520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between anti-survivin antibody and survivin mRNA expression in head and neck cancer patients.
    Uemura N; Kodama S; Nomi N; Okamoto T; Suzuki M
    Acta Otolaryngol; 2010 Aug; 130(8):959-65. PubMed ID: 20100132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitor of apoptosis in lung cancer Livin perioperative clinical research].
    Wang LN; Mou J; Zhang YB; Dong P; Diao X; Wang SY; Chen H; Liu YF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Sep; 26(9):889-90. PubMed ID: 20815986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [RNAi-mediated gene silencing of livin synergistic with epirubicin enhance apoptosis of human breast cancer cells].
    Liang CY; Ma P; Liu XL
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1703-6. PubMed ID: 19024543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
    Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B
    Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.